Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (161-170 of 230) with videos related to

Pageof 23
Sort By:
Diabetologia|November 27, 2014
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes studyKwok-Leung Ong, Andrzej S Januszewski, Rachel O'Connell, et al.
Journal of Hepatology|February 24, 2015
PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitisSven Francque, An Verrijken, Sandrine Caron, et al.
Journal of Clinical Lipidology|November 12, 2019
Relationship between alirocumab, PCSK9, and LDL-C levels in four phase 3 ODYSSEY trials using 75 and 150 mg dosesJennifer G Robinson, Michel Farnier, John J P Kastelein, et al.
Diabetes Research and Clinical Practice|August 25, 2012
Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loopAntonio Ceriello, László Barkai, Jens Sandahl Christiansen, et al.
Journal of Internal Medicine|August 19, 2021
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humansJan Borén, Martin Adiels, Elias Björnson, et al.
Nature Genetics|March 3, 2004
Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)Päivi Pajukanta, Heidi E Lilja, Janet S Sinsheimer, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2016
ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal ObesityBruno Vergès, Martin Adiels, Jan Boren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2003
Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin genePhilippa J Talmud, Steve Martin, George Steiner, et al.
Circulation|March 27, 2002
Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery diseaseDavid M Flavell, Yalda Jamshidi, Emma Hawe, et al.
BMC Endocrine Disorders|November 27, 2014
Factors associated with postprandial lipemia and apolipoprotein A-V levels in individuals with familial combined hyperlipidemiaPaloma Almeda-Valdes, Daniel Cuevas-Ramos, Roopa Mehta, et al.
Pageof 23

Showing results (161-170 of 230) with videos related to

Sort By:
Pageof 23
Diabetologia|November 27, 2014
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes studyKwok-Leung Ong, Andrzej S Januszewski, Rachel O'Connell, et al.
Journal of Hepatology|February 24, 2015
PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitisSven Francque, An Verrijken, Sandrine Caron, et al.
Journal of Clinical Lipidology|November 12, 2019
Relationship between alirocumab, PCSK9, and LDL-C levels in four phase 3 ODYSSEY trials using 75 and 150 mg dosesJennifer G Robinson, Michel Farnier, John J P Kastelein, et al.
Diabetes Research and Clinical Practice|August 25, 2012
Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loopAntonio Ceriello, László Barkai, Jens Sandahl Christiansen, et al.
Journal of Internal Medicine|August 19, 2021
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humansJan Borén, Martin Adiels, Elias Björnson, et al.
Nature Genetics|March 3, 2004
Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)Päivi Pajukanta, Heidi E Lilja, Janet S Sinsheimer, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2016
ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal ObesityBruno Vergès, Martin Adiels, Jan Boren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 15, 2003
Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin genePhilippa J Talmud, Steve Martin, George Steiner, et al.
Circulation|March 27, 2002
Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery diseaseDavid M Flavell, Yalda Jamshidi, Emma Hawe, et al.
BMC Endocrine Disorders|November 27, 2014
Factors associated with postprandial lipemia and apolipoprotein A-V levels in individuals with familial combined hyperlipidemiaPaloma Almeda-Valdes, Daniel Cuevas-Ramos, Roopa Mehta, et al.
Pageof 23